Conjunctival Melanoma and Cell-Free DNA Regression With Ipilimumab/Nivolumab and Stereotactic Radiosurgery.
Overview
publication date
- August 15, 2023
published in
Research
keywords
- Conjunctival Neoplasms
- Ipilimumab
- Melanoma
- Nivolumab
- Radiosurgery
Identity
PubMed Central ID
- PMC10867273
Scopus Document Identifier
- 85189139089
Digital Object Identifier (DOI)
- 10.1097/IOP.0000000000002490
PubMed ID
- 37581882
Additional Document Info
has global citation frequency
volume
- 40
issue
- 3